RVL Pharmaceuticals plc Operating Lease Right-of-Use Assets
RVL Pharmaceuticals plc had Operating Lease Right-of-Use Assets of $365.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-08-14
- 2023-06-30: Operating Lease, Right-of-Use Asset $365.00K.
- 2023-03-31: Operating Lease, Right-of-Use Asset $522.00K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $512.00K.
- 2022-09-30: Operating Lease, Right-of-Use Asset $708.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2023-06-30 | $365.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $522.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $512.00K 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $708.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $871.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.12M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.37M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.65M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.34M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.39M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.95M 10-K · filed 2022-03-30 | $2.75M 10-K · filed 2021-03-30 |
| 2020-09-30 | $3.23M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $3.66M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $4.47M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $3.92M 8-K · filed 2021-09-08 | $4.98M 10-K · filed 2020-03-19 |
| 2019-09-30 | $5.56M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $6.38M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $6.36M 10-Q · filed 2019-05-09 | |
| 2019-01-01 | $6.04M 10-K · filed 2020-03-19 | $6.04M 10-Q · filed 2019-05-09 |